Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/5/2020
SIETES contiene 93011 citas

 
 
 1 a 20 de 213 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Zhu H, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Starub L, Huybrechts KF. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020;369:20 de mayo. [Ref.ID 103628]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
3.Enlace a cita original Cita con resumen
Pasternak B, Wintzell V, Furu K, Engeland A, Neovius M, Stephansson O. Oral fluconazole in pregnancy and risk of stillbirth and neonatal death. JAMA 2018;319:12 de junio. [Ref.ID 102789]
4.Enlace a cita original Cita con resumen
Kreijkamp-Kaspers S, Hawke KL, van Driel ML. Oral medications to treat toenail fungal infection. JAMA 2018;319:23 de enero. [Ref.ID 102528]
5. Cita con resumen
Chang S-H, Chou I-J, Yeh Y-H, Chiou M-J, Wen M-S, Kuo C-T, See L-C, Kuo C-F. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 2017;318:1250-9. [Ref.ID 102073]
6. Cita con resumen
Anónimo. Métoclopramide, dompéridone: morts subites, arythmies ventriculaires. Prescrire 2016;36:351-4. [Ref.ID 100540]
7.Enlace a cita originalTiene citas relacionadas Cita con resumen
Anónimo. FDA Drug Safety Communication: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy . U.S. Food and Drug Administration 2016:26 de abril. [Ref.ID 100206]
8. Cita con resumen
Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]
9.Tiene citas relacionadas Cita con resumen
Woloshin S, Schwartz LM. US Food and Drug Administration approval of flibanserin. Even the score does not add up . JAMA Intern Med 2016;176:439-42. [Ref.ID 100071]
10.Tiene citas relacionadas Cita con resumen
Molgaard-Nielsen D, Svanström H, Melbye M, Hviid A, Pasternak B. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA 2016;315:58-67. [Ref.ID 99952]
11. Cita con resumen
Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]
12. Cita con resumen
Anónimo. Suvorexant (Belsomra) for insomnia. Med Lett Drugs Ther 2015;57:29-31. [Ref.ID 98878]
13.Tiene citas relacionadas Cita con resumen
Molgaard-Nielsen D, Pasternak B, Hviid A. Oral fluconazole during pregnancy and risk of birth defects. N Engl J Med 2013;369:2061-2. [Ref.ID 96580]
14.Tiene citas relacionadas Cita con resumen
Vlachadis N, LLiodromiti Z, Vrachnis N. Oral fluconazole during pregnancy and risk of birth defects. N Engl J Med 2013;369:2061. [Ref.ID 96579]
15. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
16.Tiene citas relacionadas Cita con resumen
Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med 2013;369:830-9. [Ref.ID 96065]
17.
Kauffman CA, Pappas PG, Patterson TF. Current concepts: fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013;368:2495-500. [Ref.ID 95738]
18.Enlace a cita original
Lestner JM, Smith PB, Cohen-Wolkowiez M, Benjamin Jr DK, Hope WW. Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective. Br J Clin Pharmacol 2013;75:1381-5. [Ref.ID 95565]
19.Enlace a cita original
Egunsola O, Adefurin A, Fakis A, Jacqz-Aigrain E, Choonara I, Sammons H. Safety of fluconazole in paediatrics: a systematic review. Eur J Clin Pharmacol 2013;69:1211-21. [Ref.ID 95557]
20. Cita con resumen
Anónimo. FDA says chronic, high-dose fluconazole use might carry risk for birth defects . U.S. Food and Drug Administration 2011:1. [Ref.ID 90912]
Seleccionar todas
 
 1 a 20 de 213 siguiente >>